Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-cell Data. | Curr Med Chem | 2025 | 38659264 | PubTator, text mining | PubMed |
| [Brain and blisters: a special bond]. | Tijdschr Gerontol Geriatr | 2024 | 40767069 | PubTator, text mining | PubMed |
| Linear IgA bullous dermatosis-a fifty year experience of Warsaw Center of bullous diseases. | Front Immunol | 2024 | 39877369 | PubTator, text mining | PubMed |
| Direct Immunofluorescence in Oral Lichen Planus and Related Lesions: Sensitivity, Specificity, and Diagnostic Accuracy in a Single Diagnostic Center in Poland. | Dent J (Basel) | 2024 | 39727453 | PubTator, text mining | PubMed |
| Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production. | Mol Ther Methods Clin Dev | 2024 | 39687728 | PubTator, text mining | PubMed |
| ADAM10 Expression by Ameloblasts Is Essential for Proper Enamel Formation. | Int J Mol Sci | 2024 | 39684894 | PubTator, text mining | PubMed |
| Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230. | Front Immunol | 2024 | 39676877 | PubTator, text mining | PubMed |
| PPP1R14B as a potential biomarker for the identification of diagnosis and prognosis affecting tumor immunity, proliferation and migration in prostate cancer. | J Cancer | 2024 | 39668827 | PubTator, text mining | PubMed |
| Ocular Mucous Membrane Pemphigoid Demonstrates a Distinct Autoantibody Profile from Those of Other Autoimmune Blistering Diseases: A Preliminary Study. | Antibodies (Basel) | 2024 | 39584991 | PubTator, text mining | PubMed |
| An expanded view of cell competition. | Development | 2024 | 39560103 | PubTator, text mining | PubMed |
| A rare case and literature review of bullous pemphigoid appearing in the setting of lichen sclerosus: a dermatopathological conundrum and what to expect. | Acta Dermatovenerol Alp Pannonica Adriat | 2024 | 39494547 | PubTator, text mining | PubMed |
| Rotating cell culture system-induced injectable self-assembled microtissues with epidermal stem cells for full-thickness skin repair. | PeerJ | 2024 | 39494298 | PubTator, text mining | PubMed |
| Clinical manifestation variability of bullous pemphigoid. | Bratisl Lek Listy | 2024 | 39487837 | PubTator, text mining | PubMed |
| Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review). | Adv Ther | 2024 | 39425892 | PubTator, text mining | PubMed |
| A Case of Acquired Factor V Inhibitor During Bullous Pemphigoid Treatment. | Cureus | 2024 | 39391459 | PubTator, text mining | PubMed |
| Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer. | Front Immunol | 2024 | 39376555 | PubTator, text mining | PubMed |
| Perinatal Outcome of Pemphigoid Gestationis: A Report of Three Cases and Review of the Literature. | Cureus | 2024 | 39371863 | PubTator, text mining | PubMed |
| Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: A cluster analysis. | J Dermatol Sci | 2024 | 39358056 | PubTator, text mining | PubMed |
| Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis. | JAMA Dermatol | 2024 | 39356527 | PubTator, text mining | PubMed |
| Expression, DNA methylation pattern and transcription factor EPB41L3 in gastric cancer: a study of 262 cases. | Cell Commun Signal | 2024 | 39354571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=11